Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity ‐score matched study

Depression and Anxiety, EarlyView.

Source: Depression and Anxiety - May 7, 2018 Category: Psychiatry Authors: Roy H.PerlisMD, MSc , RajeshMehtaRPh, MS , Alison M.EdwardsMStat , ArunTiwariMBA , Guido W.ImbensPhD Source Type: research